Update: Iroko Pharmaceuticals Reports Encouraging Results from Study of Naproxen Formulated Using a Proprietary, Patented, Nano Technology Platform - Drugs.com MedNews
Links shared publicly online about this topic.
- 552total visits
Update: Iroko Pharmaceuticals Reports Encouraging Results from Study of Naproxen Formulated Using a Proprietary, Patented, Nano Technology Platform - Drugs.com MedNews
Jan 26, 2011 - Iroko Pharmaceuticals, LLC announced on January 6, 2011 the results of its Phase I clinical study of its unique formulation of naproxen, a widely
View full resource at drugs.com
Tags: Arthritis Medication, Drug, Pharma, Naprosyn, Aleve, Midol Extended Relief
Most Recently Shared on January 26, 2011 at 6:15 pm By:
Update:Â Iroko Pharmaceuticals Reports Encouraging Results from Study of Naproxen Formulated Using a Propri... http://bit.ly/faEBxm #drug
Advertisement
